These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 2843634

  • 1. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
    Sanders-Bush E, Burris KD, Knoth K.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
    [Abstract] [Full Text] [Related]

  • 2. (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist.
    Burris KD, Breeding M, Sanders-Bush E.
    J Pharmacol Exp Ther; 1991 Sep; 258(3):891-6. PubMed ID: 1679849
    [Abstract] [Full Text] [Related]

  • 3. 5-HT-induced transferrin production by choroid plexus epithelial cells in culture: role of 5-HT1c receptor.
    Tsutsumi M, Sanders-Bush E.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):253-7. PubMed ID: 2164094
    [Abstract] [Full Text] [Related]

  • 4. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors.
    Conn PJ, Sanders-Bush E.
    J Pharmacol Exp Ther; 1987 Aug; 242(2):552-7. PubMed ID: 3039120
    [Abstract] [Full Text] [Related]

  • 5. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
    Sanders-Bush E, Breeding M.
    J Pharmacol Exp Ther; 1990 Mar; 252(3):984-8. PubMed ID: 2319481
    [Abstract] [Full Text] [Related]

  • 6. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
    Pierce PA, Peroutka SJ.
    J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
    [Abstract] [Full Text] [Related]

  • 7. Phosphoinositide hydrolysis linked 5-HT2 receptors in fibroblasts from choroid plexus.
    Barker EL, Burris KD, Sanders-Bush E.
    Brain Res; 1991 Jun 28; 552(2):330-2. PubMed ID: 1655172
    [Abstract] [Full Text] [Related]

  • 8. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ, Aghajanian GK.
    J Pharmacol Exp Ther; 1996 Sep 28; 278(3):1373-82. PubMed ID: 8819525
    [Abstract] [Full Text] [Related]

  • 9. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
    Sanders-Bush E, Breeding M.
    J Pharmacol Exp Ther; 1988 Oct 28; 247(1):169-73. PubMed ID: 3139864
    [Abstract] [Full Text] [Related]

  • 10. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D, Helsley S, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 Dec 28; 122(3):237-43. PubMed ID: 8748393
    [Abstract] [Full Text] [Related]

  • 11. Characterization of 5-hydroxytryptamine receptors on isolated ovine uterine artery in late pregnancy.
    Zhang L, Dyer DC.
    J Pharmacol Exp Ther; 1990 Jun 28; 253(3):1236-44. PubMed ID: 2359025
    [Abstract] [Full Text] [Related]

  • 12. Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.
    Mokler DJ, Commissaris RL, Warner MR, Rech RH.
    J Pharmacol Exp Ther; 1983 Dec 28; 227(3):557-62. PubMed ID: 6655557
    [Abstract] [Full Text] [Related]

  • 13. Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex.
    Muschamp JW, Regina MJ, Hull EM, Winter JC, Rabin RA.
    Brain Res; 2004 Oct 08; 1023(1):134-40. PubMed ID: 15364028
    [Abstract] [Full Text] [Related]

  • 14. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
    Schindler EA, Harvey JA, Aloyo VJ.
    Brain Res; 2013 Jan 23; 1491():98-108. PubMed ID: 23123701
    [Abstract] [Full Text] [Related]

  • 15. Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs.
    Sanders-Bush E, Breeding M.
    Psychopharmacology (Berl); 1991 Jan 23; 105(3):340-6. PubMed ID: 1665919
    [Abstract] [Full Text] [Related]

  • 16. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP, Waldman SR, Marona-Lewicka D, Wainscott DB, Nelson DL, Sanders-Bush E, Nichols DE.
    J Med Chem; 1997 Sep 12; 40(19):2997-3008. PubMed ID: 9301661
    [Abstract] [Full Text] [Related]

  • 17. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
    Arvanov VL, Liang X, Russo A, Wang RY.
    Eur J Neurosci; 1999 Sep 12; 11(9):3064-72. PubMed ID: 10510170
    [Abstract] [Full Text] [Related]

  • 18. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD, Sanders-Bush E.
    Mol Pharmacol; 1992 Nov 12; 42(5):826-30. PubMed ID: 1359397
    [Abstract] [Full Text] [Related]

  • 19. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line.
    Ivins KJ, Molinoff PB.
    Mol Pharmacol; 1990 May 12; 37(5):622-30. PubMed ID: 2160057
    [Abstract] [Full Text] [Related]

  • 20. Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats.
    Marona-Lewicka D, Kurrasch-Orbaugh DM, Selken JR, Cumbay MG, Lisnicchia JG, Nichols DE.
    Psychopharmacology (Berl); 2002 Oct 12; 164(1):93-107. PubMed ID: 12373423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.